Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03755947
Brief Title: Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia

First Submitted : November 20, 2018
First Submitted that Met QC Criteria : November 26, 2018
First Posted : November 28, 2018

Last Update Submitted that Met QC Criteria : April 24, 2019
Last Update Posted : April 26, 2019